Todorovic Smilja, Akpinar Asli, Assunção Ricardo, Bär Cornelia, Bavaro Simona L, Berkel Kasikci Muzeyyen, Domínguez-Soberanes Julieta, Capozzi Vittorio, Cotter Paul D, Doo Eun-Hee, Gündüz Ergün Burcu, Guzel Mustafa, Harsa Hayriye S, Hastaoglu Emre, Humblot Christèle, Hyseni Bahtir, Hosoglu Muge I, Issa Aline, Karakaş-Budak Barçın, Karakaya Sibel, Kesenkas Harun, Keyvan Erhan, Künili Ibrahim E, Kütt Mary-Liis, Laranjo Marta, Louis Sandrine, Mantzouridou Fani T, Matalas Antonia, Mayo Baltasar, Mojsova Sandra, Mukherjee Arghya, Nikolaou Anastasios, Ortakci Fatih, Paveljšek Diana, Perrone Giancarlo, Pertziger Eugenia, Santa Dushica, Sar Taner, Savary-Auzeloux Isabelle, Schwab Clarissa, Starowicz Małgorzata, Stojanović Marko, Syrpas Michail, Tamang Jyoti P, Yerlikaya Oktay, Yilmaz Birsen, Malagon-Rojas Jeadran, Salminen Seppo, Frias Juana, Chassard Christophe, Vergères Guy
Institute for Biological Research Sinisa Stankovic, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Department of Food Engineering, Manisa Celal Bayar University Faculty of Engineering and Natural Science, Manisa, Türkiye.
Front Nutr. 2024 Sep 3;11:1458536. doi: 10.3389/fnut.2024.1458536. eCollection 2024.
Worldwide, fermented foods (FF) are recognized as healthy and safe. Despite the rapid increase of research papers, there is a lack of systematic evaluation of the health benefits and risks of FF. The COST Action CA20128 "Promoting innovation of fermented foods" (PIMENTO) aims to provide a comprehensive assessment on the available evidence by compiling a set of 16 reviews. Seven reviews will cover clinical and biological endpoints associated with major health indicators across several organ systems, including the cardiovascular, gastrointestinal, neurological, immune, and skeletal systems. Nine reviews will address broader biological questions associated with FF including bioactive compounds and vitamin production, nutrient bioavailability and bioaccessibility, the role of FF in healthy diets and personalized nutrition, food safety, regulatory practices, and finally, the health properties of novel and ethnic FF. For each outcome assessed in the reviews, an innovative approach will be adopted based on EFSA's published guidance for health claim submissions. In particular, each review will be composed of three parts: (1) a systematic review of available human studies; (2) a non-systematic review of the mechanism of action related to the clinical endpoints measured by the human studies identified in part 1; and (3) a non-systematic review of the characterization of the FF investigated in the human studies identified in part 1. The evidence and research gaps derived from the reviews will be summarized and published in the form of a strategic road map that will pave the way for future research on FF.
在全球范围内,发酵食品被认为是健康且安全的。尽管研究论文数量迅速增加,但对于发酵食品的健康益处和风险仍缺乏系统性评估。欧洲科学技术合作组织(COST)的CA20128行动“促进发酵食品创新”(PIMENTO)旨在通过编撰16篇综述来对现有证据进行全面评估。其中7篇综述将涵盖与多个器官系统主要健康指标相关的临床和生物学终点,包括心血管系统、胃肠道系统、神经系统、免疫系统和骨骼系统。另外9篇综述将探讨与发酵食品相关的更广泛生物学问题,包括生物活性化合物和维生素的产生、营养素的生物利用度和生物可及性、发酵食品在健康饮食和个性化营养中的作用、食品安全、监管实践,以及新型和民族发酵食品的健康特性。对于综述中评估的每个结果,将根据欧洲食品安全局(EFSA)发布的健康声明提交指南采用创新方法。具体而言,每篇综述将由三个部分组成:(1)对现有人体研究的系统综述;(2)对与第1部分中确定的人体研究测量的临床终点相关作用机制的非系统综述;(3)对第1部分中确定的人体研究中所调查发酵食品特性的非系统综述。从这些综述中得出的证据和研究空白将以战略路线图的形式进行总结和发布,这将为未来发酵食品的研究铺平道路。